Entera Bio (ENTX) Competitors $1.55 -0.08 (-4.91%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ENTX vs. ACB, TRVI, BMEA, TCRX, STRO, CYBN, MOLN, MGNX, SOPH, and ZNTLShould you be buying Entera Bio stock or one of its competitors? The main competitors of Entera Bio include Aurora Cannabis (ACB), Trevi Therapeutics (TRVI), Biomea Fusion (BMEA), TScan Therapeutics (TCRX), Sutro Biopharma (STRO), Cybin (CYBN), Molecular Partners (MOLN), MacroGenics (MGNX), SOPHiA GENETICS (SOPH), and Zentalis Pharmaceuticals (ZNTL). These companies are all part of the "pharmaceutical products" industry. Entera Bio vs. Aurora Cannabis Trevi Therapeutics Biomea Fusion TScan Therapeutics Sutro Biopharma Cybin Molecular Partners MacroGenics SOPHiA GENETICS Zentalis Pharmaceuticals Aurora Cannabis (NASDAQ:ACB) and Entera Bio (NASDAQ:ENTX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, community ranking, analyst recommendations, valuation and institutional ownership. Which has more volatility and risk, ACB or ENTX? Aurora Cannabis has a beta of 1.87, indicating that its share price is 87% more volatile than the S&P 500. Comparatively, Entera Bio has a beta of 1.58, indicating that its share price is 58% more volatile than the S&P 500. Do analysts rate ACB or ENTX? Entera Bio has a consensus price target of $10.00, suggesting a potential upside of 545.16%. Given Entera Bio's higher possible upside, analysts clearly believe Entera Bio is more favorable than Aurora Cannabis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Entera Bio 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals believe in ACB or ENTX? 47.6% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 14.1% of Entera Bio shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by insiders. Comparatively, 10.9% of Entera Bio shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has higher valuation and earnings, ACB or ENTX? Entera Bio has lower revenue, but higher earnings than Aurora Cannabis. Entera Bio is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurora Cannabis$200.35M1.16-$48.62M-$0.76-5.58Entera Bio$130K426.61-$8.89M-$0.26-5.96 Does the MarketBeat Community believe in ACB or ENTX? Aurora Cannabis received 202 more outperform votes than Entera Bio when rated by MarketBeat users. However, 67.55% of users gave Entera Bio an outperform vote while only 59.44% of users gave Aurora Cannabis an outperform vote. CompanyUnderperformOutperformAurora CannabisOutperform Votes38159.44% Underperform Votes26040.56% Entera BioOutperform Votes17967.55% Underperform Votes8632.45% Is ACB or ENTX more profitable? Entera Bio has a net margin of 0.00% compared to Aurora Cannabis' net margin of -17.47%. Aurora Cannabis' return on equity of -2.19% beat Entera Bio's return on equity.Company Net Margins Return on Equity Return on Assets Aurora Cannabis-17.47% -2.19% -1.56% Entera Bio N/A -107.24%-92.29% Does the media prefer ACB or ENTX? In the previous week, Entera Bio had 1 more articles in the media than Aurora Cannabis. MarketBeat recorded 5 mentions for Entera Bio and 4 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 0.75 beat Entera Bio's score of 0.05 indicating that Aurora Cannabis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Entera Bio 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryAurora Cannabis and Entera Bio tied by winning 8 of the 16 factors compared between the two stocks. Ad Porter & CompanyThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. Get Entera Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ENTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ENTX vs. The Competition Export to ExcelMetricEntera BioBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$58.33M$2.95B$5.06B$8.89BDividend YieldN/A1.90%4.97%4.06%P/E Ratio-5.9617.8689.0213.30Price / Sales426.61222.321,207.2881.01Price / CashN/A160.0839.1736.03Price / Book8.614.906.085.74Net Income-$8.89M-$41.63M$119.07M$225.93M7 Day Performance-11.43%-4.73%-1.84%-1.32%1 Month Performance-16.22%-6.53%-3.65%0.60%1 Year Performance112.33%25.63%31.62%26.23% Entera Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ENTXEntera Bio2.0329 of 5 stars$1.55-4.9%$10.00+545.2%+112.3%$58.33M$130,000.00-5.9620Gap UpACBAurora Cannabis0.6391 of 5 stars$4.24+1.4%N/A-11.0%$232.52M$200.35M-5.581,073TRVITrevi Therapeutics3.4144 of 5 stars$2.77-7.7%$7.43+168.2%+113.1%$230.60MN/A0.0020BMEABiomea Fusion3.4346 of 5 stars$6.28-2.2%$30.50+385.7%-39.1%$227.58MN/A-1.5750TCRXTScan Therapeutics2.6162 of 5 stars$4.12-2.1%$12.00+191.3%-10.6%$223.02M$21.05M0.00100STROSutro Biopharma4.5351 of 5 stars$2.67-1.1%$12.14+354.8%-3.6%$222.64M$153.73M0.00240Analyst ForecastAnalyst RevisionCYBNCybin1.4673 of 5 stars$11.14+1.2%$138.00+1,139.3%N/A$222.59MN/A-1.6750Analyst ForecastGap UpMOLNMolecular Partners0.389 of 5 stars$5.20-4.8%$4.50-13.5%+19.8%$220.24M$7.84M0.00180MGNXMacroGenics3.8684 of 5 stars$3.28-5.7%$7.63+132.5%-57.0%$218.42M$58.75M0.00430SOPHSOPHiA GENETICS1.4237 of 5 stars$3.17-3.1%$6.50+105.0%-14.6%$213.78M$62.37M0.00520ZNTLZentalis Pharmaceuticals2.5838 of 5 stars$3.13+4.7%$10.00+219.5%-71.1%$213.08MN/A0.00160Analyst Revision Related Companies and Tools Related Companies Aurora Cannabis Competitors Trevi Therapeutics Competitors Biomea Fusion Competitors TScan Therapeutics Competitors Sutro Biopharma Competitors Cybin Competitors Molecular Partners Competitors MacroGenics Competitors SOPHiA GENETICS Competitors Zentalis Pharmaceuticals Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ENTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | SponsoredJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...Priority Gold | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump said you could learn something from this manEarly Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide vic...Wide Moat Research | SponsoredThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of ...WealthPress | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entera Bio Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Entera Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
